Compare stocks

Dottikon ES Holding AG is a Switzerland-based company specializing in the production of high-quality performance chemicals for the pharmaceutical and chemical industries. It primarily focuses on hazardous chemical reactions, leveraging its expertise in safety and reliability to deliver a range of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1913, the company has a long-standing presence in the chemical industry. Headquartered in Dottikon, Switzerland, the company strategically emphasizes its capabilities in complex chemical processes to serve a global clientele. Dottikon's operations are supported by its state-of-the-art facilities which enable it to handle chemically intensive processes efficiently and safely.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.